Jakafi

Jakafi (ruxolitinib) is a medication used to treat certain blood disorders, such as myelofibrosis and polycythemia vera. It works by blocking specific proteins involved in the overproduction of blood cells, helping to reduce symptoms like enlarged spleen and fatigue. Jakafi can also help manage symptoms of other related conditions by calming overactive signaling pathways in the bone marrow. It is taken orally as a tablet and requires careful monitoring by a healthcare provider due to potential side effects. Overall, Jakafi offers a targeted approach to improve quality of life in affected patients.